Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 164

1.

Comparison of humoral and cellular immune responses to inactivated swine influenza virus vaccine in weaned pigs.

Platt R, Vincent AL, Gauger PC, Loving CL, Zanella EL, Lager KM, Kehrli ME Jr, Kimura K, Roth JA.

Vet Immunol Immunopathol. 2011 Aug 15;142(3-4):252-7. doi: 10.1016/j.vetimm.2011.05.005. Epub 2011 May 7.

PMID:
21664701
2.

Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (δ-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus.

Gauger PC, Vincent AL, Loving CL, Lager KM, Janke BH, Kehrli ME Jr, Roth JA.

Vaccine. 2011 Mar 24;29(15):2712-9. doi: 10.1016/j.vaccine.2011.01.082. Epub 2011 Feb 23.

PMID:
21310191
3.

The immune response and maternal antibody interference to a heterologous H1N1 swine influenza virus infection following vaccination.

Kitikoon P, Nilubol D, Erickson BJ, Janke BH, Hoover TC, Sornsen SA, Thacker EL.

Vet Immunol Immunopathol. 2006 Aug 15;112(3-4):117-28. Epub 2006 Apr 18.

PMID:
16621020
5.

Immunogenicity and protective efficacy of an elastase-dependent live attenuated swine influenza virus vaccine administered intranasally in pigs.

Masic A, Lu X, Li J, Mutwiri GK, Babiuk LA, Brown EG, Zhou Y.

Vaccine. 2010 Oct 8;28(43):7098-108. doi: 10.1016/j.vaccine.2010.08.003. Epub 2010 Aug 12.

PMID:
20708697
6.

Vaccine-associated enhanced respiratory disease does not interfere with the adaptive immune response following challenge with pandemic A/H1N1 2009.

Gauger PC, Loving CL, Lager KM, Janke BH, Kehrli ME Jr, Roth JA, Vincent AL.

Viral Immunol. 2013 Oct;26(5):314-21. doi: 10.1089/vim.2013.0018. Epub 2013 Sep 13.

PMID:
24033080
7.

The influence of age and maternal antibodies on the postvaccinal response against swine influenza viruses in pigs.

Markowska-Daniel I, Pomorska-Mól M, Pejsak Z.

Vet Immunol Immunopathol. 2011 Jul 15;142(1-2):81-6. doi: 10.1016/j.vetimm.2011.03.019. Epub 2011 Mar 31.

PMID:
21501880
8.
9.

Failure of protection and enhanced pneumonia with a US H1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccine.

Vincent AL, Lager KM, Janke BH, Gramer MR, Richt JA.

Vet Microbiol. 2008 Jan 25;126(4):310-23. Epub 2007 Jul 17.

PMID:
17719188
10.

Reassortant H1N1 influenza virus vaccines protect pigs against pandemic H1N1 influenza virus and H1N2 swine influenza virus challenge.

Yang H, Chen Y, Shi J, Guo J, Xin X, Zhang J, Wang D, Shu Y, Qiao C, Chen H.

Vet Microbiol. 2011 Sep 28;152(3-4):229-34. doi: 10.1016/j.vetmic.2011.04.032. Epub 2011 Apr 30.

PMID:
21596495
11.

Efficacy of swine influenza A virus vaccines against an H3N2 virus variant.

Lee JH, Gramer MR, Joo HS.

Can J Vet Res. 2007 Jul;71(3):207-12.

12.
13.

Protection against a European H1N2 swine influenza virus in pigs previously infected with H1N1 and/or H3N2 subtypes.

Van Reeth K, Gregory V, Hay A, Pensaert M.

Vaccine. 2003 Mar 28;21(13-14):1375-81.

PMID:
12615433
14.

Live attenuated influenza A virus vaccine protects against A(H1N1)pdm09 heterologous challenge without vaccine associated enhanced respiratory disease.

Gauger PC, Loving CL, Khurana S, Lorusso A, Perez DR, Kehrli ME Jr, Roth JA, Golding H, Vincent AL.

Virology. 2014 Dec;471-473:93-104. doi: 10.1016/j.virol.2014.10.003. Epub 2014 Oct 28.

15.

Poly I:C adjuvanted inactivated swine influenza vaccine induces heterologous protective immunity in pigs.

Thomas M, Wang Z, Sreenivasan CC, Hause BM, Gourapura J Renukaradhya, Li F, Francis DH, Kaushik RS, Khatri M.

Vaccine. 2015 Jan 15;33(4):542-8. doi: 10.1016/j.vaccine.2014.11.034. Epub 2014 Nov 28.

PMID:
25437101
16.

Kinetics of lung lesion development and pro-inflammatory cytokine response in pigs with vaccine-associated enhanced respiratory disease induced by challenge with pandemic (2009) A/H1N1 influenza virus.

Gauger PC, Vincent AL, Loving CL, Henningson JN, Lager KM, Janke BH, Kehrli ME Jr, Roth JA.

Vet Pathol. 2012 Nov;49(6):900-12. doi: 10.1177/0300985812439724. Epub 2012 Mar 28.

PMID:
22461226
17.

Efficacy of commercial swine influenza vaccines against challenge with a recent European H1N1 field isolate.

Kyriakis CS, Gramer MR, Barbé F, Van Doorsselaere J, Van Reeth K.

Vet Microbiol. 2010 Jul 29;144(1-2):67-74. doi: 10.1016/j.vetmic.2009.12.039. Epub 2010 Jan 11.

PMID:
20116942
19.

Efficacy of influenza vaccination and tamiflu® treatment--comparative studies with Eurasian Swine influenza viruses in pigs.

Duerrwald R, Schlegel M, Bauer K, Vissiennon T, Wutzler P, Schmidtke M.

PLoS One. 2013 Apr 22;8(4):e61597. doi: 10.1371/journal.pone.0061597. Print 2013.

20.

Seroprevalence and risk factors of swine influenza in Spain.

Simon-Grifé M, Martín-Valls GE, Vilar MJ, García-Bocanegra I, Mora M, Martín M, Mateu E, Casal J.

Vet Microbiol. 2011 Apr 21;149(1-2):56-63. doi: 10.1016/j.vetmic.2010.10.015. Epub 2010 Nov 4.

PMID:
21112702

Supplemental Content

Support Center